Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000180717 | SCV000233198 | uncertain significance | not provided | 2015-02-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001852256 | SCV002216602 | uncertain significance | Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2022-07-26 | criteria provided, single submitter | clinical testing | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 1106 of the CRB1 protein (p.Tyr1106Cys). This variant is present in population databases (rs115649214, gnomAD 0.007%). This missense change has been observed in individual(s) with retinitis pigmentosa (Invitae). ClinVar contains an entry for this variant (Variation ID: 199199). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CRB1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV003454474 | SCV004180148 | uncertain significance | Leber congenital amaurosis 8 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454475 | SCV004180149 | uncertain significance | Pigmented paravenous retinochoroidal atrophy | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454473 | SCV004180150 | uncertain significance | Retinitis pigmentosa 12 | 2023-04-11 | criteria provided, single submitter | clinical testing |